NCI | Technology Transfer

MESOTHELIN-TARGETED CAR T CELLS WITH INCREASED ANTI-TUMOR EFFICACY,
PERSISTENCE AND RESILIENCE AND USE THEREOF FOR THE TREATMENT OF MESOTHELINPOSITIVE CANCERS

Read more about MESOTHELIN-TARGETED CAR T CELLS WITH INCREASED ANTI-TUMOR EFFICACY, PERSISTENCE AND RESILIENCE AND USE THEREOF FOR THE TREATMENT OF MESOTHELINPOSITIVE CANCERS

US Application 63/730,757
Filed on 2024-12-11

VIRUS ANTIGEN-DERIVED IMMUNOGENIC PEPTIDES AND THEIR USE FOR THE PREVENTION AND TREATMENT OF HEPATOCELLULAR CARCINOMA

Read more about VIRUS ANTIGEN-DERIVED IMMUNOGENIC PEPTIDES AND THEIR USE FOR THE PREVENTION AND TREATMENT OF HEPATOCELLULAR CARCINOMA

US Application 63/735,040
Filed on 2024-12-17

T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53

Read more about T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53

Russia
2024132889
Filed on 2024-11-01

CANCER VACCINE AND METHOD OF USE THEREOF

Read more about CANCER VACCINE AND METHOD OF USE THEREOF

US Application 63/702,726
Filed on 2024-10-03

Particle Scaffolds for Tissue Reconstruction

Read more about Particle Scaffolds for Tissue Reconstruction

US Application 63/710,652
Filed on 2024-10-23

IMMUNOGENS AND METHODS FOR INDUCING AN IMMUNE RESPONSE

Read more about IMMUNOGENS AND METHODS FOR INDUCING AN IMMUNE RESPONSE

US Application 63/708,594
Filed on 2024-10-17

LINKER FOR ANTIBODY-DRUG CONJUGATES AND ANTIBODY-DRUG CONJUGATES COMPRISING THE LINKER

Read more about LINKER FOR ANTIBODY-DRUG CONJUGATES AND ANTIBODY-DRUG CONJUGATES COMPRISING THE LINKER

US Application 63/728,960
Filed on 2024-12-06

VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1

Read more about VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1

US Application 18/864,213
Filed on 2024-11-08

VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1

Read more about VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1

India
202417088469
Filed on 2024-11-15

VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1

Read more about VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1

Australia
2023268543
Filed on 2024-11-14

Subscribe to NCI